Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis.
In an era when women were not admitted to the University of Edinburgh and when England's first female physician (Elizabeth Garrett Anderson, 1836-1917) had to venture to Paris, France, to earn her M.D. in 1870, the career of Mary Broadfoot Walker (Figure 1) (1988-1974) stands out for truly remarkable achievement. She is credited with making the most significant discovery in medical therapeutic within the British empire.
Keeney
A H
AH
University of Louisville, School of Medicine, KY 40292, USA.
Keeney
V T
VT
D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000266:history*; D009388:Neostigmine / Q000266:history* / Q000627:therapeutic use; D009885:Ophthalmology / Q000266:history*; D006113:United Kingdom
D009388:Neostigmine